The country’s leading quoted CBD wellness and medicinal cannabis group

About us

CBD you can trust

Sativa Group plc is the UK’s leading quoted CBD wellness and medicinal cannabis group with four revenue generating operating subsidiaries. It also has a research division that holds Home Office licences, and is developing medicines for the veterinary and human markets, supported by our Scientific Advisory Board.

Our Mission

Sativa Group’s strategy is focused on the smart-sourcing of the raw materials, advanced extraction, manufacture, testing, distribution, as well as the research & development, of medicinal cannabis and cannabinoid products.

Our Vision

To build the UK’s leading CBD Wellness brands and to develop innovative medicinal and veterinary cannabis products to answer the unmet needs of consumers and patients.

Latest updates

ANNOUNCEMENT: Conditional CSE Approval of Sativa Wellness Group Inc

The Company is pleased to announce that the Canadian Securities Exchange (“CSE”) conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa shareholders voted 99% in favour of the merger, with Stillcanna shareholders voting 99.9% in favour, and the Court sanctioned the Scheme of Arrangement, subject to unconditional CSE approval. Unconditional approval and the resumption of trading on the CSE of Sativa Wellness Group Inc.

ANNOUNCEMENT: Court Sanction of Scheme of Arrangement and update to timetable Suspension

Further to the announcement issued by the Company on 1 September 2020, the Company is pleased to announce that yesterday the Court sanctioned the Scheme in connection with the recommended offer by Stillcanna for the entire issued share capital of the Company to be satisfied by the issuance of shares in Stillcanna.

Notwithstanding the sanctioning of the Scheme by the Court, it has been ordered that upon receipt (but not before) by the Company from Stillcanna of the unconditional approval given to it by the Canadian Securities Exchange of the Acquisition undertaken pursuant to the Scheme (“CSE Approval”), the Order of the Court be produced to the Registrar of Companies of England and Wales and that an office copy be delivered to the Registrar together with a copy of the CSE Approval. The Scheme will only become effective on the date upon which the Order of the Court and a copy of the CSE Approval is filed with the Registrar of Companies in England and Wales (the “Scheme Effective Date”)…

Niche, innovative brands tailored to each audience

Goodbody Botanicals is aimed at the UK’s major grocers, high street pharmacies and retailers, as well as independent pharmacies throughout the country. The brand and packaging is seen as industry-leading by numerous retailers.
Goodbody Wellness focuses on the health and beauty markets. The brand sells products to specialty retailers as well as through three company-owned Goodbody Wellness stores.

Tessellate Collective sells CBD products through the direct marketing channel.

PhytoVista Laboratories is a leading UK testing laboratory for cannabis-based CBD products.


Backed up by a laboratory

Sativa brings together professionals with extensive commercial, retail, finance, medical, veterinary, pharmacological, scientific, governance and regulatory experience and is working in conjunction with King’s College London on research to develop innovative solutions that meet consumer and patient demand.